---
title: "Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems"
ocid: "ocds-h6vhtk-029880"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029880"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029880.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029880.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS BLOOD & TRANSPLANT"
published: "2021-03-04"
---

# Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems

Buyer: NHS BLOOD & TRANSPLANT  
Current stage: Award  
OCID: ocds-h6vhtk-029880

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029880)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029880.json)

## Summary

The procurement process involves NHS Blood & Transplant (NHSBT) seeking suppliers for Human Leucocyte Antigen (HLA) specific antibody detection and definition systems, classified under biomedical equipment. The contract has reached the award stage, with a total value of £7,020,000 for the HLA Antibody Detection and Definition Systems lot, awarded to both Immucor and VH Bio Ltd. The secondary lot for the maintenance of existing Luminex systems has a value of £123,000 and was awarded to Immucor. The framework agreement, which is effective for four years, applies to a deliverable network across six locations in the UK, including Birmingham and Newcastle, and must comply with the open procurement method.

This tender presents significant opportunities for businesses specialising in biomedical equipment and related services, particularly those involved in histocompatibility, immunogenetics, or medical equipment maintenance. Small and medium-sized enterprises (SMEs) and larger suppliers with expertise in HLA antibody testing and laboratory technologies would be well-positioned to compete. As the NHSBT will collaborate closely with successful suppliers, those who can deliver efficient, timely, and cost-effective solutions are likely to succeed in this competitive market.

## Notice

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor

### Lot Information

HLA Antibody Detection and Definition Systems

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor

Maintenance of Existing Luminex Systems

Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/004395-2021 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 4 Mar 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 22 Feb 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £7,143,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS BLOOD & TRANSPLANT |
| Locality | FILTON, BRISTOL |
| Post town | Bristol |
| Postcode | BS34 7QH |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK5 West of England |
| ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire |
| Local authority | South Gloucestershire |
| Electoral ward | Filton |
| Westminster constituency | Filton and Bradley Stoke |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 2 |
| Supplier names | IMMUCOR; VH BIO |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products
- 38 - Laboratory, optical and precision equipments (excl. glasses)
- 50 - Repair and maintenance services

### Codes

- 33100000 - Medical equipments
- 33140000 - Medical consumables
- 33141625 - Diagnostic kits
- 38434540 - Biomedical equipment
- 50421000 - Repair and maintenance services of medical equipment

## Release History

- 4 Mar 2021 at 22:56 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/004395-2021

## Notice URLs

- http://www.nhsbt.nhs.uk
- https://ted.europa.eu/udl?uri=TED:NOTICE:565906-2019:TEXT:EN:HTML

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029880. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029880.json.